Assura (ARSSF) Stock Price, News & Analysis

Company Overview

Assura plc is a national healthcare premises specialist and UK REIT based in Altrincham, UK - caring for more than 600 primary healthcare buildings, from which over six million patients are served. A constituent of the FTSE 250 and the EPRA indices, as at 30 September 2023, Assura's portfolio was valued at £2.7 billion. At Assura, we BUILD for health. Assura builds better spaces for people and places, invests in skills and inspires new ways of working, and unlocks the power of design and innovation to deliver lasting impact for communities - aiming for six million people to have benefitted from improvements to and through its healthcare buildings by 2026. Assura is leading for a sustainable future, targeting net zero carbon across its portfolio by 2040.

Key Stats

• Today's Range: $0.61 to $0.61
• 50-Day Range: $0.54 to $0.64
• 52-Week Range: $0.43 to $0.64
• Volume: N/A
• Average Volume: 11,794 shs
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

ARSSF Stock Analysis - Frequently Asked Questions

How have ARSSF shares performed this year?

Assura's stock was trading at $0.4910 on January 1st, 2025. Since then, ARSSF shares have increased by 23.3% and is now trading at $0.6055.
View the best growth stocks for 2025 here.

How do I buy shares of Assura?

Shares of ARSSF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

• Today: 4/25/2025
• Next Earnings (Estimated): 5/19/2025

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Real Estate
• Industry: REIT - Healthcare Facilities
• Sub-Industry: N/A
• Current Symbol: OTCMKTS:ARSSF
• CIK: N/A
• Web: www.assuraplc.com
• Phone: 44-1925-420660
• Fax: N/A
• Employees: 86
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A